Isu Abxis ranked among the top searched stocks for 3 days within the past month.


As of 2:30 PM on the 30th, Isu Abxis is trading at 12,850 KRW, down 1.15% from the previous day. This represents a 41.68% increase compared to March 3. Isu Abxis, an affiliate of the Isu Group, is known as a company that develops antibiotic treatments and provides medical services.

Over the past 5 days, individual investors have net purchased 1,230,275 shares, while foreigners and institutions have net sold 40,889 shares and net purchased 8,066 shares, respectively.


On March 29, Isu Abxis became a market issue with the announcement, "Commencement of technology transfer for the pilot production of the COVID-19 Russian vaccine..."



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing